Assessing the potential relevance of CEACAM6 as a blood transcriptional biomarker [version 2; peer review: 1 approved, 2 approved with reservations]
Background Changes in blood transcript abundance levels have been associated with pathogenesis in a wide range of diseases. While next generation sequencing technology can measure transcript abundance on a genome-wide scale, downstream clinical applications often require small sets of genes to be se...
שמור ב:
| Principais autores: | , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
F1000 Research Ltd
2024-04-01
|
| סדרה: | F1000Research |
| נושאים: | |
| גישה מקוונת: | https://f1000research.com/articles/11-1294/v2 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|